Free shipping across Canada on orders over $400 CAD
Skip to content
99.7%Purity by HPLC
Quantity
10 mg per vial
CAS
77591-33-4
Mol. weight
889.0 g/mol
Formula
C38H68N10O14
Current lot
TB-2609-49
Certificate of analysis

TB-500 Lyophilized Powder, 10 mg Vial, ≥99% HPLC

  • Quantity per vial10 mg
  • FormLyophilized powder
  • Purity≥99% by HPLC
  • Identity methodMass spectrometry

$129.99

10 mg of TB-500 per vial, lyophilized, ≥99% by HPLC with identity confirmed by mass spectrometry. Lot-specific certificate of analysis available for download.

120 in stock

Free shipping over $400Ships from CanadaSecure checkoutPrices in CAD
Research dataResearch use only
Purity (HPLC)
99.7%
Quantity
10 mg per vial
Form
Lyophilized powder in a sealed 3 mL glass vial
Molecular formula
C38H68N10O14
Molecular weight
889.0 g/mol
CAS number
77591-33-4
Storage
Lyophilized powder: store sealed at -20 °C, protected from light and moisture. Ships at ambient temperature with desiccant.
Certificate of analysisThird-party HPLC and mass-spec report for this lot

For laboratory research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not for human consumption. Sold to qualified researchers and institutions for in-vitro research. Handle in accordance with your institution's safety guidelines.

Sequence7 residues
LKKTETQ
hydrophobicpolaracidicbasicGly / Pro
Lot panel
Lot numberTB-2609-49
Tested2026-09-22
MethodsHPLCMS
Download the certificatePDF · HPLC and MS report for this lot
  • -20 °Cstore sealed, frozen
  • Lightprotect from light
  • Drydesiccant, keep dry
  1. 1Packed coldSealed vial, insulated mailer, desiccant
  2. 2Shipped trackedNext business day
  3. 3Straight to the freezerLog the lot against the certificate
Dosage calculator

Vial content and diluent volume → concentration, volume per draw and insulin-syringe units (U-100).

Concentration
—
Volume per draw
—
Syringe units (U-100)
—
Draws per vial
—

Laboratory preparation arithmetic (1 mL = 100 units on a U-100 syringe). No guidance on use. For laboratory research only; not for human or veterinary use.

Also known as: Thymosin beta-4 fragment (17-23); Tβ4 fragment All listings for CAS 77591-33-4 →

Spend more, save more
  • Orders over $100−5%SAVE5
  • Orders over $200−10%SAVE10

Each vial contains 10 mg of TB-500, a synthetic fragment of thymosin beta-4, supplied as a lyophilized powder. Purity is ≥99% by HPLC, with identity confirmed by mass spectrometry, and a lot-specific certificate of analysis is available for download. The compound is sold for research use only.

Why the ≥99% HPLC figure and the CAS number matter

Purity with its method

The figure is ≥99% by HPLC, not a generic grade claim. A purchasing officer can compare that number against a specification sheet directly.

Identity confirmation

Mass spectrometry confirms identity alongside the HPLC purity figure. Two methods, two lines on the certificate.

Documented identifiers

Molecular formula C38H68N10O14, molecular weight 889.0 g/mol, CAS 77591-33-4. These allow the material to be logged in an inventory system without guesswork.

Certificate per lot

The certificate of analysis is lot-specific and downloadable, so records match the vial actually received.

Quantity stated per vial

Net content is 10 mg per vial. This item is supplied as a single vial.

Specifications

Identity
Synthetic fragment of thymosin beta-4
Quantity per vial
10 mg
Form
Lyophilized powder
Purity
≥99% by HPLC
Identity method
Mass spectrometry
Molecular formula
C38H68N10O14
Molecular weight
889.0 g/mol
CAS number
77591-33-4
Storage
Lyophilized powder: store sealed at -20 °C, protected from light and moisture
Shipping condition
Ambient temperature with desiccant
Ships from
Richmond, BC, in an insulated mailer with desiccant
Packed weight
0.05 kg (courier weight, not net content)
Package dimensions
8 × 8 × 6 cm
Price
$129.99 CAD

Who the 10 mg TB-500 vial suits

The 10 mg vial fits an in-vitro laboratory that works through a single compound over several experiments and wants one lot number covering all of them. It also fits a purchasing officer who must file identity and purity documentation before the material enters a reagent inventory, since the certificate of analysis names the lot, the ≥99% HPLC purity and the mass spectrometry confirmation. Ordering is limited to laboratories and qualified researchers. Store the sealed vial at -20 °C, protected from light and moisture, and retain the lot-specific certificate with the sample record. For laboratory research use only. Not for human or veterinary use.

Common questions

Does the certificate of analysis match the vial I receive?

Yes. The certificate of analysis is lot-specific and available for download, stating purity of ≥99% by HPLC and identity confirmed by mass spectrometry.

How should the vial be stored once it arrives?

The lyophilized powder should be stored sealed at -20 °C, protected from light and moisture.

How is the order shipped, and who may order it?

Orders ship from Richmond, BC at ambient temperature in an insulated mailer with desiccant, and the material is sold to laboratories and qualified researchers for research use only.

How it compares

TB-500 Lyophilized Powder, 10 mg Vial, ≥99% HPLC next to MOTS-c 20 mg Lyophilized Vial, ≥99% by HPLC (at the same price) and BPC-157 Lyophilized Powder, 10 mg per Vial ($35.00 less).

TB-500 Lyophilized Powder, 10 mg Vial, ≥99% HPLC this pageMOTS-c 20 mg Lyophilized Vial, ≥99% by HPLCBPC-157 Lyophilized Powder, 10 mg per Vial
Price$129.99$129.99$94.99
Quantity10 mg per vial20 mg per vial10 mg per vial
Purity99.7% (HPLC)99.3% (HPLC)99.7% (HPLC)
Molecular weight889.0 g/mol2174.6 g/mol1419.5 g/mol
FormulaC38H68N10O14C101H152N28O22S2C62H98N16O22
CAS77591-33-41627580-64-6137525-51-0
FormLyophilized powder in a sealed 3 mL glass vialLyophilized powder in a sealed 3 mL glass vialLyophilized powder in a sealed 3 mL glass vial
PubMed

Peer-reviewed literature

Journal articles indexed in PubMed for TB-500. Provided as bibliographic reference only; they do not describe this product or any use of it.

  1. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansMayfield CK, Bolia IK, Feingold CL et al. · The American journal of sports medicine (2026)PMID 41476424DOI 10.1177/03635465251357593
  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsRahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2026)PMID 41490200DOI 10.5435/JAAOSGlobal-D-25-00236
  3. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceMendias CL, Awan TM · Sports medicine (Auckland, N.Z.) (2026)PMID 41966639DOI 10.1007/s40279-026-02437-0
  4. Sympathomimetic amines and cardiac arrhythmiasOppenheimer E, Akavia E, Shavit S et al. · Cardiovascular research (1990)PMID 1977520DOI 10.1093/cvr/24.9.754
See all 27 PubMed results for TB-500 →

Last updated September 23, 2026

Complete the set

Shop now☎